Literature DB >> 14759634

The use of complementary and alternative medicines by patients with peripheral neuropathy.

Brian Brunelli1, Kenneth C Gorson.   

Abstract

Complementary and alternative medicine (CAM) therapies have become increasingly popular and are used regularly by patients with chronic neurological disorders. The prevalence and characteristics of CAM use by patients with peripheral neuropathy is unknown. We performed a prospective, questionnaire-based study to determine the prevalence and patterns of use of CAM therapies in 180 consecutive outpatients with peripheral neuropathy. The use of CAM was reported by 77 patients (43%) with neuropathy. The most frequent were megavitamins (35%), magnets (30%), acupuncture (30%), herbal remedies (22%), and chiropractic manipulation (21%); 37 (48%) tried more than one form of alternative treatment. Seventeen respondents (27%) thought their neuropathy symptoms improved with these approaches. Those who used CAM were slightly younger (mean age 62 vs. 65 years, p = 0.05) and more often college educated (39% vs. 24%, p = 0.03) compared to CAM nonusers. They also more often reported burning neuropathic pain (62% vs. 44%, p = 0.01). Patients with diabetic neuropathy used CAM more frequently than others (p = 0.03). The most common reason for using CAM was inadequate pain control (32%). Almost half of patients did not consult a physician before starting CAM. We conclude that there is a high prevalence of CAM use in our patients with neuropathy, and one-quarter reported that their symptoms improved. CAM users were better educated than nonusers, but most did not discuss CAM treatments with their physician. Neuropathic pain was substantially more common in CAM users, and lack of pain control was the most common reason for CAM use.

Entities:  

Mesh:

Year:  2004        PMID: 14759634     DOI: 10.1016/j.jns.2003.10.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  26 in total

1.  Complementary and alternative medicine use among US adults with common neurological conditions.

Authors:  Rebecca Erwin Wells; Russell S Phillips; Steven C Schachter; Ellen P McCarthy
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

2.  Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy: a pilot study.

Authors:  Jinny Tavee; Mary Rensel; Sarah M Planchon; Robert S Butler; Lael Stone
Journal:  Int J MS Care       Date:  2011

3.  Trachyspermum ammi 10 % topical cream versus placebo on neuropathic pain, a randomized, double-blind, placebo-controlled trial.

Authors:  Peyman Petramfar; Mahmoodreza Moein; Soliman Mohammadi Samani; Sayed Hamidreza Tabatabaei; Mohammad M Zarshenas
Journal:  Neurol Sci       Date:  2016-05-11       Impact factor: 3.307

4.  A Randomized Clinical Trial of Group Acupuncture for Painful Diabetic Neuropathy Among Diverse Safety Net Patients.

Authors:  Maria T Chao; Dean Schillinger; Unity Nguyen; Trilce Santana; Rhianon Liu; Steve Gregorich; Frederick M Hecht
Journal:  Pain Med       Date:  2019-11-01       Impact factor: 3.750

5.  Complementary and alternative medicine use by patients visiting a free health clinic: A single-site, pilot study.

Authors:  Patrick G Clay; Kevin A Clauson; Alan Glaros
Journal:  Curr Ther Res Clin Exp       Date:  2004-11

6.  Electroacupuncture alleviates chemotherapy-induced pain through inhibiting phosphorylation of spinal CaMKII in rats.

Authors:  Y Zhang; A Li; J Xin; K Ren; B M Berman; L Lao; R-X Zhang
Journal:  Eur J Pain       Date:  2017-10-16       Impact factor: 3.931

Review 7.  Gynecologic management of neuropathic pain.

Authors:  Frank F Tu; Kevin M Hellman; Miroslav M Backonja
Journal:  Am J Obstet Gynecol       Date:  2011-05-12       Impact factor: 8.661

8.  Antiallodynic effects of acupuncture in neuropathic rats.

Authors:  Myeoung Hoon Cha; Ji Soo Choi; Sun Joon Bai; Insop Shim; Hye-Jung Lee; Sun Mi Choi; Bae Hwan Lee
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

9.  Centella asiatica triterpenes for diabetic neuropathy: a randomized, double-blind, placebo-controlled, pilot clinical study.

Authors:  Jau-Shin Lou; Diana M Dimitrova; Charles Murchison; Grace C Arnold; Heather Belding; Nick Seifer; Ngoc Le; Sarah B Andrea; Nora E Gray; Kirsten M Wright; Maya Caruso; Amala Soumyanath
Journal:  Esper Dermatol       Date:  2018-06

10.  Painful diabetic peripheral neuropathy: Health care costs and complications from 2010 to 2015.

Authors:  Musa Kiyani; Zidanyue Yang; Lefko T Charalambous; Syed M Adil; Hui-Jie Lee; Siyun Yang; Promila Pagadala; Beth Parente; Susan E Spratt; Shivanand P Lad
Journal:  Neurol Clin Pract       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.